You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
|
|---|---|
| Published in |
New England Journal of Medicine, December 2018
|
| DOI | 10.1056/nejmoa1814468 |
| Pubmed ID | |
| Authors |
Marc Carrier, Karim Abou-Nassar, Ranjeeta Mallick, Vicky Tagalakis, Sudeep Shivakumar, Ariah Schattner, Philip Kuruvilla, Danny Hill, Silvana Spadafora, Katerine Marquis, Mateya Trinkaus, Anna Tomiak, Agnes Y Y Lee, Peter L Gross, Alejandro Lazo-Langner, Robert El-Maraghi, Glenwood Goss, Gregoire Le Gal, David Stewart, Timothy Ramsay, Marc Rodger, Debra Witham, Philip S Wells |
X Demographics
The data shown below were collected from the profiles of 700 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 137 | 20% |
| Spain | 61 | 9% |
| Canada | 48 | 7% |
| United Kingdom | 27 | 4% |
| France | 23 | 3% |
| Colombia | 15 | 2% |
| Japan | 12 | 2% |
| Mexico | 11 | 2% |
| Brazil | 11 | 2% |
| Other | 94 | 13% |
| Unknown | 261 | 37% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 457 | 65% |
| Practitioners (doctors, other healthcare professionals) | 116 | 17% |
| Scientists | 107 | 15% |
| Science communicators (journalists, bloggers, editors) | 18 | 3% |
| Unknown | 2 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 455 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 455 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 67 | 15% |
| Researcher | 62 | 14% |
| Student > Bachelor | 44 | 10% |
| Student > Postgraduate | 40 | 9% |
| Student > Doctoral Student | 37 | 8% |
| Other | 96 | 21% |
| Unknown | 109 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 218 | 48% |
| Pharmacology, Toxicology and Pharmaceutical Science | 34 | 7% |
| Biochemistry, Genetics and Molecular Biology | 13 | 3% |
| Agricultural and Biological Sciences | 9 | 2% |
| Nursing and Health Professions | 8 | 2% |
| Other | 31 | 7% |
| Unknown | 142 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 605. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2023.
All research outputs
#38,376
of 25,782,229 outputs
Outputs from New England Journal of Medicine
#1,399
of 32,678 outputs
Outputs of similar age
#704
of 448,452 outputs
Outputs of similar age from New England Journal of Medicine
#32
of 260 outputs
Altmetric has tracked 25,782,229 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,678 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.7. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,452 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 260 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.